• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调控去泛素化酶的酶活性和细胞功能的机制。

Mechanisms orchestrating the enzymatic activity and cellular functions of deubiquitinases.

机构信息

Laboratory for Cell Signaling and Cancer, Maisonneuve-Rosemont Hospital Research Center, Montréal, Québec, Canada.

Laboratory for Cell Signaling in Immunotherapy, Maisonneuve-Rosemont Hospital Research Center, Montréal, Québec, Canada; Department of Medicine, University of Montréal, Montréal, Québec, Canada.

出版信息

J Biol Chem. 2022 Aug;298(8):102198. doi: 10.1016/j.jbc.2022.102198. Epub 2022 Jun 25.

DOI:10.1016/j.jbc.2022.102198
PMID:35764170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9356280/
Abstract

Deubiquitinases (DUBs) are required for the reverse reaction of ubiquitination and act as major regulators of ubiquitin signaling processes. Emerging evidence suggests that these enzymes are regulated at multiple levels in order to ensure proper and timely substrate targeting and to prevent the adverse consequences of promiscuous deubiquitination. The importance of DUB regulation is highlighted by disease-associated mutations that inhibit or activate DUBs, deregulating their ability to coordinate cellular processes. Here, we describe the diverse mechanisms governing protein stability, enzymatic activity, and function of DUBs. In particular, we outline how DUBs are regulated by their protein domains and interacting partners. Intramolecular interactions can promote protein stability of DUBs, influence their subcellular localization, and/or modulate their enzymatic activity. Remarkably, these intramolecular interactions can induce self-deubiquitination to counteract DUB ubiquitination by cognate E3 ubiquitin ligases. In addition to intramolecular interactions, DUBs can also oligomerize and interact with a wide variety of cellular proteins, thereby forming obligate or facultative complexes that regulate their enzymatic activity and function. The importance of signaling and post-translational modifications in the integrated control of DUB function will also be discussed. While several DUBs are described with respect to the multiple layers of their regulation, the tumor suppressor BAP1 will be outlined as a model enzyme whose localization, stability, enzymatic activity, and substrate recognition are highly orchestrated by interacting partners and post-translational modifications.

摘要

去泛素化酶(DUBs)是泛素化反应的逆反应所必需的,它们是泛素信号过程的主要调节剂。新出现的证据表明,这些酶在多个水平上受到调节,以确保适当和及时的底物靶向,并防止随机去泛素化的不利后果。疾病相关突变抑制或激活 DUBs,使其协调细胞过程的能力失调,这凸显了 DUB 调节的重要性。在这里,我们描述了控制 DUB 蛋白稳定性、酶活性和功能的多种机制。特别是,我们概述了 DUB 如何受到其蛋白结构域和相互作用伙伴的调节。分子内相互作用可以促进 DUB 的蛋白稳定性,影响其亚细胞定位,并/或调节其酶活性。值得注意的是,这些分子内相互作用可以诱导自身去泛素化,以抵消同源 E3 泛素连接酶对 DUB 的泛素化。除了分子内相互作用外,DUB 还可以寡聚化并与多种细胞蛋白相互作用,从而形成调节其酶活性和功能的必需或可选复合物。信号转导和翻译后修饰在 DUB 功能的综合调控中的重要性也将进行讨论。虽然有几种 DUBs 因其多层次的调节而被描述,但肿瘤抑制因子 BAP1 将被概述为一种模型酶,其定位、稳定性、酶活性和底物识别都受到相互作用伙伴和翻译后修饰的高度协调。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/ea490eddf8d9/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/7df868ff36fa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/168ccb201583/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/f3d37a81df99/gr3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/ab5f695689b4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/d1deeaac99bc/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/ea490eddf8d9/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/7df868ff36fa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/168ccb201583/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/f3d37a81df99/gr3a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/ab5f695689b4/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/d1deeaac99bc/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aae/9356280/ea490eddf8d9/gr6.jpg

相似文献

1
Mechanisms orchestrating the enzymatic activity and cellular functions of deubiquitinases.调控去泛素化酶的酶活性和细胞功能的机制。
J Biol Chem. 2022 Aug;298(8):102198. doi: 10.1016/j.jbc.2022.102198. Epub 2022 Jun 25.
2
Deubiquitinases in cancer.癌症中的去泛素化酶。
Nat Rev Cancer. 2023 Dec;23(12):842-862. doi: 10.1038/s41568-023-00633-y. Epub 2023 Nov 7.
3
The emerging roles of deubiquitinases in plant proteostasis.去泛素化酶在植物蛋白稳态中的新兴作用。
Essays Biochem. 2022 Aug 5;66(2):147-154. doi: 10.1042/EBC20210060.
4
Deubiquitinases: Modulators of Different Types of Regulated Cell Death.去泛素化酶:不同类型调控细胞死亡的调节剂。
Int J Mol Sci. 2021 Apr 21;22(9):4352. doi: 10.3390/ijms22094352.
5
Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response.去泛素化酶(DUBs):调控、动态平衡和氧化应激反应。
J Biol Chem. 2021 Sep;297(3):101077. doi: 10.1016/j.jbc.2021.101077. Epub 2021 Aug 12.
6
Mechanisms of Deubiquitinase Specificity and Regulation.去泛素化酶特异性和调控的机制。
Annu Rev Biochem. 2017 Jun 20;86:159-192. doi: 10.1146/annurev-biochem-061516-044916. Epub 2017 May 12.
7
Deubiquitylases in developmental ubiquitin signaling and congenital diseases.发育泛素信号通路中的去泛素化酶及先天性疾病
Cell Death Differ. 2021 Feb;28(2):538-556. doi: 10.1038/s41418-020-00697-5. Epub 2020 Dec 17.
8
UL36 Encoded by Marek's Disease Virus Exhibits Linkage-Specific Deubiquitinase Activity.UL36 编码的马立克氏病病毒具有连锁特异性去泛素化酶活性。
Int J Mol Sci. 2020 Mar 5;21(5):1783. doi: 10.3390/ijms21051783.
9
Elucidating the role of ubiquitination and deubiquitination in osteoarthritis progression.阐明泛素化和去泛素化在骨关节炎进展中的作用。
Front Immunol. 2023 Jun 9;14:1217466. doi: 10.3389/fimmu.2023.1217466. eCollection 2023.
10
Identification of Deubiquitinase Substrates in Xenopus Egg Extract.爪蟾卵提取物中去泛素化酶底物的鉴定。
Methods Mol Biol. 2023;2591:219-236. doi: 10.1007/978-1-0716-2803-4_13.

引用本文的文献

1
TNF receptor-associated factors: promising targets of natural products for the treatment of osteoporosis.肿瘤坏死因子受体相关因子:天然产物治疗骨质疏松症的潜在靶点
Front Physiol. 2025 May 27;16:1527814. doi: 10.3389/fphys.2025.1527814. eCollection 2025.
2
The deubiquitinase USP7 stabilizes HER2 expression and promotes breast cancer progression.去泛素化酶USP7可稳定HER2表达并促进乳腺癌进展。
Neoplasia. 2025 Aug;66:101192. doi: 10.1016/j.neo.2025.101192. Epub 2025 Jun 4.
3
p53 inhibits OTUD5 transcription to promote GPX4 degradation and induce ferroptosis in gastric cancer.
p53抑制OTUD5转录以促进GPX4降解并诱导胃癌中的铁死亡。
Clin Transl Med. 2025 Mar;15(3):e70271. doi: 10.1002/ctm2.70271.
4
Deubiquitinase dynamics: methodologies for understanding substrate interactions.去泛素化酶动力学:理解底物相互作用的方法
BMB Rep. 2025 May;58(5):191-202. doi: 10.5483/BMBRep.2025-0011.
5
Ubiquitin-specific protease 25 improves myocardial ischemia-reperfusion injury by deubiquitinating NLRP3 and negatively regulating NLRP3 inflammasome activity in cardiomyocytes.泛素特异性蛋白酶25通过去泛素化NLRP3并负向调节心肌细胞中的NLRP3炎性小体活性来改善心肌缺血再灌注损伤。
Clin Transl Med. 2025 Feb;15(2):e70243. doi: 10.1002/ctm2.70243.
6
Caspase 3-specific cleavage of ubiquitin-specific peptidase 48 enhances drug-induced apoptosis in AML.泛素特异性肽酶48的半胱天冬酶3特异性切割增强了急性髓系白血病中药物诱导的细胞凋亡。
Cancer Biol Ther. 2025 Dec;26(1):2459426. doi: 10.1080/15384047.2025.2459426. Epub 2025 Jan 29.
7
Genetic Code Expansion Approaches to Decipher the Ubiquitin Code.遗传密码扩展方法解析泛素密码。
Chem Rev. 2024 Oct 23;124(20):11544-11584. doi: 10.1021/acs.chemrev.4c00375. Epub 2024 Sep 23.
8
Cell-Based Covalent-Capture Deubiquitinase Assay for Inhibitor Discovery.用于抑制剂发现的基于细胞的共价捕获去泛素化酶检测法
ACS Pharmacol Transl Sci. 2024 Aug 16;7(9):2827-2839. doi: 10.1021/acsptsci.4c00331. eCollection 2024 Sep 13.
9
Therapeutic Targeting of the GLS1-c-Myc Positive Feedback Loop Suppresses Glutaminolysis and Inhibits Progression of Head and Neck Cancer.靶向 GLS1-c-Myc 正反馈环抑制谷氨酰胺代谢抑制头颈部癌症进展。
Cancer Res. 2024 Oct 1;84(19):3223-3234. doi: 10.1158/0008-5472.CAN-24-0254.
10
DoUBLing up: ubiquitin and ubiquitin-like proteases in genome stability.双重打击:泛素和泛素样蛋白酶与基因组稳定性。
Biochem J. 2024 Apr 10;481(7):515-545. doi: 10.1042/BCJ20230284.